HELP     Sign In
Search

Relevance to Autism

Rare mutations in the CTTNBP2 gene were originally reported in individuals with autism in Cheung et al., 2001; however, genetic association was not found in this report when allele frequencies were compared to the control cohort. A de novo LoF variant in the CTTNBP2 gene was identified in an ASD proband from the Simons Simplex Collection (PMID 22542183). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CTTNBP2 as a gene meeting high statistical significance with a 0.01 < FDR 0.05, meaning that this gene had a 95% chance of being a true autism gene (PMID 25363760). Functional analysis of ASD-associated CTTNBP2 variants (originally reported in De Rubeis et al., 2014) in Shih et al., 2020 found that four ASD-associated variants resulted in reduced dendritic spine density in cultured hippocampal neurons; furthermore, mice that were heterozygous for the ASD-associated p.Met121Ile variant (p.Met120Ile in mouse) exhibited reduced dendritic spine density and reduced social interactions. Shih et al., 2022 reported that liquid-liquid phase separation and zinc-induced liquid-to-gel phase transition regulated the synaptic distribution and protein-protein interaction of CTTNBP2, which formed self-assembled condensates throught its C-terminal intrinsically disordered region and facilitated SHANK3 co-condensation at dendritic spines, while zinc was found to bind to CTTNBP2, promoting higher-order assemblies and leading to reduced mobility and enhanced stability and synaptic retention of CTTNBP2 condensates; ASD-linked mutations were subsequently found to alter condensate formation and synaptic retention of CTTNBP2 and impaired mouse social behaviors, which could be ameliorated by zinc supplementation.

Molecular Function

A similar gene in rat interacts with a central regulator of the actin cytoskeleton.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Identification of the human cortactin-binding protein-2 gene from the autism candidate region at 7q31.
ASD
Support
Mutational Landscape of Autism Spectrum Disorder Brain Tissue
ASD
Support
CTTNBP2 Controls Synaptic Expression of Zinc-Related Autism-Associated Proteins and Regulates Synapse Formation and Autism-like Behaviors
ASD
Support
Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks.
ASD
Support
Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model.
ASD
Support
De novo genic mutations among a Chinese autism spectrum disorder cohort.
ASD
Support
Sex bias in social deficits, neural circuits and nutrient demand in Cttnbp2 autism models
ASD
Support
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
ID
Epilepsy, ASD
Support
Integrating de novo and inherited variants in 42
ASD
Support
De novo gene disruptions in children on the autistic spectrum.
ASD
Highly Cited
Transcription-dependent spatial arrangements of CFTR and adjacent genes in human cell nuclei.
Recent Recommendation
Autism-linked mutations of CTTNBP2 reduce social interaction and impair dendritic spine formation via diverse mechanisms
ASD
Recent Recommendation
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD
Recent Recommendation
Phase separation and zinc-induced transition modulate synaptic distribution and association of autism-linked CTTNBP2 and SHANK3
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN054R001 
 missense_variant 
 c.3729T>G 
 p.Leu1213Val 
  
  
  
 GEN054R002 
 synonymous_variant 
 G>T 
 p.(=) 
  
  
  
 GEN054R003 
 frameshift_variant 
 c.2279_2280del 
 p.Val760GlufsTer14 
 De novo 
  
 Simplex 
 GEN054R004 
 missense_variant 
 c.2752C>T 
 p.His918Tyr 
 De novo 
  
 Simplex 
 GEN054R005 
 frameshift_variant 
 c.4975_4976dup 
 p.Pro1661AsnfsTer31 
 Familial 
 Paternal 
 Simplex 
 GEN054R006 
 stop_gained 
 c.1606C>T 
 p.Arg536Ter 
 Familial 
 Paternal 
 Simplex 
 GEN054R007 
 stop_gained 
 c.4365G>A 
 p.Trp1455Ter 
 Familial 
 Paternal 
 Simplex 
 GEN054R008 
 missense_variant 
 c.3332A>T 
 p.Gln1111Leu 
 Familial 
 Maternal 
 Simplex 
 GEN054R009 
 missense_variant 
 c.3293G>T 
 p.Ser1098Ile 
 Familial 
 Paternal 
 Simplex 
 GEN054R010 
 missense_variant 
 c.2575C>T 
 p.Leu859Phe 
 Familial 
 Maternal 
 Simplex 
 GEN054R011 
 missense_variant 
 c.124C>T 
 p.Arg42Trp 
 Familial 
 Maternal 
 Simplex 
 GEN054R012 
 missense_variant 
 c.3940G>A 
 p.Val1314Ile 
 Familial 
 Paternal 
 Simplex 
 GEN054R013 
 missense_variant 
 c.2843G>A 
 p.Arg948Gln 
 Familial 
 Maternal 
 Simplex 
 GEN054R014 
 missense_variant 
 c.2087C>A 
 p.Thr696Asn 
 Familial 
 Paternal 
 Simplex 
 GEN054R015 
 missense_variant 
 c.1027G>A 
 p.Gly343Arg 
 Familial 
 Paternal 
 Simplex 
 GEN054R016 
 missense_variant 
 c.363G>A 
 p.Met121Ile 
 Familial 
 Maternal 
 Simplex 
 GEN054R017 
 missense_variant 
 c.337G>A 
 p.Ala113Thr 
 Familial 
 Paternal 
 Simplex 
 GEN054R018 
 frameshift_variant 
 c.4500_4501del 
 p.Ser1501LysfsTer8 
 Unknown 
  
 Unknown 
 GEN054R019 
 stop_gained 
 c.3360T>G 
 p.Tyr1120Ter 
 Unknown 
  
 Unknown 
 GEN054R020 
 frameshift_variant 
 c.3423_3424dup 
 p.Leu1142HisfsTer4 
 Unknown 
  
 Unknown 
 GEN054R021 
 stop_gained 
 c.1252C>T 
 p.Gln418Ter 
 Unknown 
  
 Unknown 
 GEN054R022 
 missense_variant 
 c.3113A>G 
 p.Asn1038Ser 
 Unknown 
  
 Unknown 
 GEN054R023 
 missense_variant 
 c.4929C>G 
 p.Asn1643Lys 
 Unknown 
  
 Unknown 
 GEN054R024 
 missense_variant 
 c.3989C>T 
 p.Ala1330Val 
 Unknown 
  
 Unknown 
 GEN054R025 
 missense_variant 
 c.2758G>T 
 p.Ala920Ser 
 Unknown 
  
 Unknown 
 GEN054R026 
 missense_variant 
 c.124C>T 
 p.Arg42Trp 
 Unknown 
  
 Unknown 
 GEN054R027 
 missense_variant 
 c.3970C>T 
 p.Arg1324Cys 
 Familial 
 Maternal 
  
 GEN054R028 
 missense_variant 
 c.3970C>T 
 p.Arg1324Cys 
 Familial 
 Paternal 
  
 GEN054R029 
 frameshift_variant 
 c.3473_3476del 
 p.Val1158GlufsTer4 
 De novo 
  
 Simplex 
 GEN054R030 
 frameshift_variant 
 c.2652_2653del 
 p.Phe884LeufsTer10 
 De novo 
  
 Simplex 
 GEN054R031 
 stop_gained 
 c.2461G>T 
 p.Gly821Ter 
 Familial 
 Paternal 
 Simplex 
 GEN054R032 
 frameshift_variant 
 c.4457del 
 p.Asn1486IlefsTer7 
 Familial 
 Paternal 
 Simplex 
 GEN054R033 
 frameshift_variant 
 c.4815dup 
 p.Val1606CysfsTer5 
 Familial 
 Paternal 
 Simplex 
 GEN054R034 
 stop_gained 
 c.2445C>G 
 p.Tyr815Ter 
 Familial 
 Paternal 
 Simplex 
 GEN054R035 
 frameshift_variant 
 c.3947dup 
 p.Gln1317SerfsTer3 
 Familial 
 Maternal 
 Simplex 
 GEN054R036 
 frameshift_variant 
 c.2651_2652del 
 p.Phe884Ter 
 Familial 
 Maternal 
 Simplex 
 GEN054R037 
 frameshift_variant 
 c.2651_2652del 
 p.Phe884Ter 
 Familial 
 Maternal 
 Simplex 
 GEN054R038 
 frameshift_variant 
 c.3947dup 
 p.Gln1317SerfsTer3 
 Familial 
 Maternal 
 Simplex 
 GEN054R039 
 frameshift_variant 
 c.4500_4501del 
 p.Ser1501LysfsTer8 
 Familial 
 Maternal 
 Multiplex 
 GEN054R040 
 splice_site_variant 
 c.4262-2A>G 
  
 Familial 
 Paternal 
 Multiplex 
 GEN054R041 
 missense_variant 
 c.4688G>T 
 p.Gly1563Val 
 Unknown 
  
  
 GEN054R042 
 missense_variant 
 c.4403G>T 
 p.Arg1468Leu 
 De novo 
  
  
 GEN054R043 
 missense_variant 
 c.3402C>A 
 p.Asp1134Glu 
 De novo 
  
  
 GEN054R044 
 missense_variant 
 c.1444C>A 
 p.Leu482Ile 
 De novo 
  
 Simplex 
 GEN054R045 
 missense_variant 
 c.344T>C 
 p.Met115Thr 
 De novo 
  
 Simplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
7
Deletion
 2
 
7
Deletion-Duplication
 28
 
7
Deletion
 3
 
7
Deletion
 3
 
7
Deletion
 1
 
7
Duplication
 1
 

Model Summary

Cttnbp2 deficiency reduces zinc levels in the brain, alters synaptic protein targeting, impairs dendritic spine formation and ultrastructure of postsynaptic density, increases activity levels, reduces anxiety levels, reduces cognitive flexibility, reduces spatial memory, reduces c-fos expression, alters NMDAR expression. Zinc supplementation rescues the synaptic expression of CTTNBP2-regulated proteins and rescues social behavior. D-cycloserine improves social behaviors of Cttnbp2-deficient mice.

References

Type
Title
Author, Year
Primary
CTTNBP2 Controls Synaptic Expression of Zinc-Related Autism-Associated Proteins and Regulates Synapse Formation and Autism-like Behaviors
Additional
Autism-linked mutations of CTTNBP2 reduce social interaction and impair dendritic spine formation via diverse mechanisms

M_CTTNBP2_1_KO_HM

Model Type: Genetic LOF
Model Genotype: Homozygous
Mutation: Mice with talen mediated frameshift deletions in exon 3 of the cttnbp2 gene generated by crossing male cttnbp2 het mice with female cttnbp2 het mice. authors previous publication used mouse line 3-1 whereas the current study uses mouse line 1-9 due to higher breeding rate. reporter thy1-eyfp mice (jackson #003782) were crossed to label neurons.
Allele Type: Knockout
Strain of Origin: NA
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 32492416

M_CTTNBP2_2_KO_HT

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Mice with talen mediated frameshift deletions in exon 3 of the cttnbp2 gene generated by crossing male cttnbp2 het mice with female cttnbp2 het mice. authors previous publication used mouse line 3-1 whereas the current study uses mouse line 1-9 due to higher breeding rate. reporter thy1-eyfp mice (jackson #003782) were crossed to label neurons.
Allele Type: Knockout
Strain of Origin: NA
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 32492416

M_CTTNBP2_3_KI_HT_R533

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Mice with the asd-linked r533* mutation in the cttnbp2 gene were generated using crispr/cas9 technology. the asd-linked mutation results in early termination of the cttnbp2 gene, i.e., r536* (corresponding to mouse r533*). mouse r533* truncated proteins lack the c-terminal p-rich domain, i.e., the cortactin binding site.
Allele Type: Knockin (asd mutation)
Strain of Origin: NA
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 32492416

M_CTTNBP2_10_KI_HT_R533

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Paired-nicking crispr/cas9 was used to insert mutant sequences into exon 4 of cttnbp2 bearing the asd mutation r533*, into hippocampal neurons
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_11_KD_BP2MIR_KI_HT_D570Y

Model Type: Genetic LOF
Model Genotype: Multifactorial
Mutation: Bp2-mir-resistant wt (control) and d570y mutant proteins cotransfected with bp2-mir or control vector ctrl-mir into hippocampal neurons. treatment of hippocampal neurons with knockdown construct bp2-mir reduces endogenous wt cttnbp2 protein.
Allele Type: Multifactorial
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_12_KI_HT_M120I

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Crispr/cas9 genomic editing technology was used to generate m120i knockin mice. to investigate dendritic spine features mice were crossed with thy1-yfp-h transgenic mice to outline neuronal morphology of forebrain projection neurons.
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_13_KI_HT_D570Y

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Crispr/cas9 genomic editing technology was used to generate d570y knockin mice. to investigate dendritic spine features mice were crossed with thy1-yfp-h transgenic mice to outline neuronal morphology of forebrain projection neurons.
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_4_KI_HT_M120I

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Paired-nicking crispr/cas9 was used to insert mutant sequences into exon 4 of cttnbp2 bearing the asd mutation m120i located in the n-terminal coiledcoil domain, which is involved in cttnbp2 hetero and homo-oligomerization, into hippocampal neurons
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_5_KI_HT_G342R

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Paired-nicking crispr/cas9 was used to insert mutant sequences into exon 4 of cttnbp2 bearing the asd mutation g342r, into hippocampal neurons
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_6_KI_HT_P353A

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Paired-nicking crispr/cas9 was used to insert mutant sequences into exon 4 of cttnbp2 bearing the asd mutation p353a, into hippocampal neurons
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_7_KI_HT_D570Y

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Paired-nicking crispr/cas9 was used to insert mutant sequences into exon 4 of cttnbp2 bearing the asd mutation d570y, in the c-terminal p-rich region, which is required for cortactin interaction, into hippocampal neurons
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_8_KI_HT_R42W

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Paired-nicking crispr/cas9 was used to insert mutant sequences into exon 4 of cttnbp2 bearing the asd mutation r42w, into hippocampal neurons
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_9_KI_HT_A112T

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Paired-nicking crispr/cas9 was used to insert mutant sequences into exon 4 of cttnbp2 bearing the asd mutation a112t, into hippocampal neurons
Allele Type: Knockin
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: 33168105

M_CTTNBP2_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: Ambulatory activity1
Increased
Description: Increased total distance travelled
 Open field test
 8 weeks
Neuroreceptor levels: glutamate receptors: NMDA receptors1
Decreased
Description: Decreased levels of grin1 and grin2a in the synaptosomal fraction; decreased levels of grin1 in the total brain homogenate
 Western blot
 Adult
Dendritic architecture: spine morphology1
Abnormal
Description: Smaller and shorter spines
 Transmission electron microscopy (TEM)
 Adult
Synaptic morphology: active zone1
Decreased
Description: Decreased number of synaptic vesicles
 Transmission electron microscopy (TEM)
 Adult
Dendritic architecture: spine density1
Decreased
Description: Fewer spines
 Transmission electron microscopy (TEM)
 Adult
Post-synaptic density size: excitatory synapses1
Decreased
Description: Decreased length and thickness of psd
 Transmission electron microscopy (TEM)
 Adult
Neuronal activation: non-familiar social interaction1
Decreased
Description: Decreased numbers of cfos-positive cells in dhip, dca1, dca3 and bla but not vca1 and vca3
 Immunohistochemistry
 2.2 months, 2.6 months
Repetitive digging1
Decreased
Description: Decrease in the number of marbles buried
 Marble-burying test
 8.6 weeks
Social memory1
Decreased
Description: Decrease in preference for an unfamiliar over a familiar mouse
 Three-chamber social approach test
 2.3 months
Social interaction1
Decreased
Description: Decrease in affiliative social interaction including head to head, head to body interactions
 Reciprocal social interaction test
 2.2 months, 2.6 months
Social approach1
Decreased
Description: Decrease in preference for an unfamiliar mouse over an object
 Three-chamber social approach test
 2.3 months
Anxiety1
Decreased
Description: Increase in time spent in the open arms
 Elevated plus maze test
 8-8.2 weeks
Spatial working memory1
Decreased
Description: Decreased preference for object at novel location
 Object-place recognition test
 8 weeks
Proteomic profile diversity1
Abnormal
Description: More than 3000 differentially expressed proteins in the synapse fraction including 19 asd-linked proteins listed in sfari spark list
 Liquid chromatography-mass spectrometry (LC-MS)
 Adult
Micronutrient level: mineral: zinc1
Decreased
Description: Decreased zinc concentration in brain tissue
 Spectrophotometry
 8 weeks
Targeted expression1
Decreased
Description: Lack of wildtype dna sequence
 DNA sequencing
 P14
Protein localization: synapse1
Decreased
Description: Shank2, shank3, strn, mob4, dpysl3, and rac3 showed reduced expression in synaptosomal fractions
 Western blot
 Adult
Targeted expression1
Decreased
Description: Absence of cttnbp2 protein in mouse brain
 Western blot
 8 weeks
Protein expression level evidence1
Increased
Description: Increased protein levels of levels of shank3, dpysl3, and rac3 in total brain lysates; no change in protein levels of shank2, strn, and mob4 in total brain lysates
 Western blot
 Adult
Targeted expression1
Decreased
Description: Absence in cttnbp2 amplicon
 Polymerase chain reaction (PCR)
 P14
Protein binding1
Decreased
Description: Lack of binding of cttnbp2 protein to shank3, shank2, and rac3
 Co-immunoprecipitation
 Adult
Size/growth1
 No change
 General observations
 Adult
Anxiety1
 No change
 Open field test
 8-8.2 weeks
Object recognition memory1
 No change
 Novel object recognition test
 8 weeks
Brain morphology1
 No change
 Histology
 Adult
Brain size1
 No change
 Gross necroscopy
 Adult
Self grooming: perseveration1
 No change
 Open field test
 8 weeks
Defecation1
 No change
 Open field test
 8 weeks
Urination1
 No change
 Open field test
 8 weeks
Vertical jumping or back flipping1
 No change
 Open field test
 8 weeks
Rearing behavior1
 No change
 Open field test
 8 weeks
 Not Reported:

M_CTTNBP2_2_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine morphology1
Abnormal
Description: Smaller width of spine heads
 Transmission electron microscopy (TEM)
 Adult
Synaptic morphology: active zone1
Decreased
Description: Decreased number of synaptic vesicles in ddg, dca3 but not dca1
 Transmission electron microscopy (TEM)
 Adult
Post-synaptic density size: excitatory synapses1
Decreased
Description: Decreased psd length in the dca1 but not ddg or dca3; decreased thickness of psd in the ddg, dca3, dca1
 Transmission electron microscopy (TEM)
 Adult
Social memory1
Decreased
Description: Decrease in preference for an unfamiliar over a familiar mouse
 Three-chamber social approach test
 2.3 months
Cognitive flexibility1
Decreased
Description: Decrease in time to learn the new location of the reward
 T-maze test
 8.1 weeks
Targeted expression1
Decreased
Description: Decrease in cttnbp2 amplicon
 Polymerase chain reaction (PCR)
 P14
Size/growth1
 No change
 General observations
 Adult
Anxiety1
 No change
 Open field test
 8-8.2 weeks
Anxiety1
 No change
 Elevated plus maze test
 8-8.2 weeks
Object recognition memory1
 No change
 Novel object recognition test
 8 weeks
Reward reinforced choice behavior1
 No change
 T-maze test
 8.1 weeks
Spatial working memory1
 No change
 Object-place recognition test
 8 weeks
General locomotor activity: Ambulatory activity1
 No change
 Open field test
 8 weeks
Brain morphology1
 No change
 Histology
 Adult
Brain size1
 No change
 Gross necroscopy
 Adult
Self grooming: perseveration1
 No change
 Open field test
 8 weeks
Defecation1
 No change
 Open field test
 8 weeks
Urination1
 No change
 Open field test
 8 weeks
Repetitive digging1
 No change
 Marble-burying test
 8.6 weeks
Vertical jumping or back flipping1
 No change
 Open field test
 8 weeks
Rearing behavior1
 No change
 Open field test
 8 weeks
Social approach1
 No change
 Three-chamber social approach test
 2.3 months
Social interaction1
 No change
 Reciprocal social interaction test
 2.2 months, 2.6 months
 Not Reported:

M_CTTNBP2_3_KI_HT_R533

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Fewer spines
 Transmission electron microscopy (TEM)
 Adult
Dendritic architecture: spine morphology1
Abnormal
Description: Smaller and shorter spines
 Transmission electron microscopy (TEM)
 Adult
Social memory1
Decreased
Description: Decrease in preference for unfamiliar social stimulus over a familiar social stimulus
 Three-chamber social approach test
 2.3 months
Social interaction1
Decreased
Description: Decrease in time spent in social interaction
 Reciprocal social interaction test
 2.2 months, 2.6 months
Ultrasonic vocalization: Isolation induced1
Decreased
Description: Decreased in duration and frequency of usv and increased in latency to first call at p6 but not p8
 Monitoring ultrasonic vocalizations
 P6, P8
Micronutrient level: mineral: zinc1
Decreased
Description: Decreased zinc concentration in brain tissue
 Spectrophotometry
 8 weeks
Size/growth1
 No change
 General observations
 Adult
Anxiety1
 No change
 Open field test
 8-8.2 weeks
Anxiety1
 No change
 Elevated plus maze test
 8-8.2 weeks
General locomotor activity: Ambulatory activity1
 No change
 Open field test
 8 weeks
Brain morphology1
 No change
 Histology
 Adult
Brain size1
 No change
 Gross necroscopy
 Adult
Social approach1
 No change
 Three-chamber social approach test
 2.3 months
 Not Reported:

M_CTTNBP2_10_KI_HT_R533

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Decreased dendritic spine density
 Immunohistochemistry
 2-3 months
Miniature post synaptic current frequency: excitatory1
Decreased
Description: Decreased mepsc frequency
 Whole-cell patch clamp
 2-3 months
Protein localization: dendritic spines1
Decreased
Description: Decreased enrichment of mutant protein in dendritic spines
 Immunohistochemistry
 2-3 months
Protein aggregation: neuronal1
 No change
 Immunohistochemistry
 2-3 months
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 2-3 months
 Not Reported:

M_CTTNBP2_11_KD_BP2MIR_KI_HT_D570Y

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Expression of the d570y mutant protein reduced dendritic spine density in bp2-mir-expressing neurons, indicating wt cttnbp2 neutralizes the impact of the d570y mutation
 Immunohistochemistry
 2-3 months
Protein localization: dendritic spines1
Decreased
Description: D570y mutant protein was much lower around the tips of dendritic spines from bp2-mirexpressing neurons
 Immunohistochemistry
 2-3 months
 Not Reported:

M_CTTNBP2_12_KI_HT_M120I

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Decreased spine density in dorsal hippocampal ca1 neurons
 Confocal microscopy
 2-3 months
Dendritic architecture: dendritic thickness1
Decreased
Description: Decreased dendritic width in dorsal hippocampal ca1 neurons
 Confocal microscopy
 2-3 months
Dendritic architecture: dendritic length1
Decreased
Description: Decreased dendritic length in dorsal hippocampal ca1 neurons
 Confocal microscopy
 2-3 months
Neuronal activation following behavioral stimulation: c-Fos levels1
Decreased
Description: Decreased neuronal activity in the ca1, ca2 and ca3 regions of hippocampus and basolateral amygdala two hours after reciprocal social interaction test
 Immunofluorescence staining
 2-3 months
Social memory1
Decreased
Description: Decreased time spent interacting with an unfamiliar social stimulus over a familiar social stimulus
 Three-chamber social approach test
 2-3 months
Social interaction1
Decreased
Description: Decreased time spent in social interaction
 Reciprocal social interaction test
 2-3 months
Social approach1
Decreased
Description: Decreased time spent interacting with a social stimulus over an object
 Three-chamber social approach test
 2-3 months
Anxiety1
 No change
 Open field test
 2-3 months
Anxiety1
 No change
 Elevated plus maze test
 2-3 months
General locomotor activity: Ambulatory activity1
 No change
 Open field test
 2-3 months
Brain anatomy1
 No change
 Histology
 2-3 months
 Not Reported:

M_CTTNBP2_13_KI_HT_D570Y

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Decreased spine density in dorsal hippocampal ca1 neurons
 Confocal microscopy
 2-3 months
Brain anatomy1
 No change
 Histology
 2-3 months
Dendritic architecture: dendritic length1
 No change
 Confocal microscopy
 2-3 months
Dendritic architecture: dendritic thickness1
 No change
 Confocal microscopy
 2-3 months
 Not Reported:

M_CTTNBP2_4_KI_HT_M120I

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Decreased dendritic spine density
 Immunohistochemistry
 2-3 months
Miniature post synaptic current frequency: excitatory1
Decreased
Description: Decreased mepsc frequency
 Whole-cell patch clamp
 2-3 months
Protein localization: dendritic spines1
Decreased
Description: Decreased enrichment of mutant protein in dendritic spines
 Immunohistochemistry
 2-3 months
Protein aggregation: neuronal1
 No change
 Immunohistochemistry
 2-3 months
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 2-3 months
 Not Reported:

M_CTTNBP2_5_KI_HT_G342R

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Decreased dendritic spine density
 Immunohistochemistry
 2-3 months
Protein aggregation: neuronal1
 No change
 Immunohistochemistry
 2-3 months
Protein localization: dendritic spines1
 No change
 Immunohistochemistry
 2-3 months
 Not Reported:

M_CTTNBP2_6_KI_HT_P353A

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Protein aggregation: neuronal1
 No change
 Immunohistochemistry
 2-3 months
Protein localization: dendritic spines1
 No change
 Immunohistochemistry
 2-3 months
Dendritic architecture: spine density1
 No change
 Immunohistochemistry
 2-3 months
 Not Reported:

M_CTTNBP2_7_KI_HT_D570Y

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Protein localization: dendritic spines1
Decreased
Description: D570y mutation alters the subcellular distribution of cttnbp2 in neurons; d570y mutant protein was lower around the tips of dendritic spines
 Immunohistochemistry
 2-3 months
Protein aggregation: neuronal1
Increased
Description: D570y mutant protein formed filamentous bundles along dendritic shafts whereas wt cttnbp2 formed punctate aggregates along dendrites
 Immunohistochemistry
 2-3 months
Cytoskeletal organization1
Abnormal
Description: Increased microtubule stabilization
 Immunohistochemistry
 2-3 months
Dendritic architecture: spine density1
 No change
 Immunohistochemistry
 2-3 months
 Not Reported:

M_CTTNBP2_8_KI_HT_R42W

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Decreased dendritic spine density
 Immunohistochemistry
 2-3 months
Protein aggregation: neuronal1
 No change
 Immunohistochemistry
 2-3 months
Protein localization: dendritic spines1
 No change
 Immunohistochemistry
 2-3 months
 Not Reported:

M_CTTNBP2_9_KI_HT_A112T

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Protein aggregation: neuronal1
 No change
 Immunohistochemistry
 2-3 months
Protein localization: dendritic spines1
 No change
 Immunohistochemistry
 2-3 months
Dendritic architecture: spine density1
 No change
 Immunohistochemistry
 2-3 months
 Not Reported:


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
CCDC136 coiled-coil domain containing 136 64753 Q96JN2 IP; LC-MS/MS
Huttlin EL , et al. 2015
CCT2 chaperonin containing TCP1, subunit 2 (beta) 10576 P78371 AP-MS
Goudreault M , et al. 2008
CCT3 chaperonin containing TCP1, subunit 3 (gamma) 7203 P49368 AP-MS
Goudreault M , et al. 2008
CCT5 chaperonin containing TCP1, subunit 5 (epsilon) 22948 P48643 AP-MS
Goudreault M , et al. 2008
CCT6A chaperonin containing TCP1, subunit 6A (zeta 1) 908 P40227 AP-MS
Goudreault M , et al. 2008
CCT8 chaperonin containing TCP1, subunit 8 (theta) 10694 P50990 AP-MS
Goudreault M , et al. 2008
CHD8 chromodomain helicase DNA binding protein 8 57680 Q9HCK8 CHIP-seq
Cotney J , et al. 2015
CTTNBP2NL CTTNBP2 N-terminal like 55917 Q9P2B4 AP-MS
Goudreault M , et al. 2008
FAM40A striatin interacting protein 1 85369 Q5VSL9 AP-MS
Goudreault M , et al. 2008
FAM40B striatin interacting protein 2 57464 Q9ULQ0 AP-MS
Goudreault M , et al. 2008
FMR1 fragile X mental retardation 1 2332 G8JLE9 PAR-CLIP
Ascano M Jr , et al. 2012
MOB4 MOB family member 4, phocein 25843 Q9Y3A3 AP-MS
Goudreault M , et al. 2008
MST4 Serine/threonine-protein kinase MST4 51765 Q9P289 AP-MS
Goudreault M , et al. 2008
PDCD10 programmed cell death 10 11235 Q9BUL8 AP-MS
Goudreault M , et al. 2008
PPP2CA protein phosphatase 2, catalytic subunit, alpha isoenzyme 5515 P67775 AP-MS
Goudreault M , et al. 2008
PPP2CB protein phosphatase 2, catalytic subunit, beta isozyme 5516 P62714 AP-MS
Goudreault M , et al. 2008
PPP2CB protein phosphatase 2, catalytic subunit, beta isozyme 5516 P62714 IP; LC-MS/MS
Huttlin EL , et al. 2015
PPP2R1A protein phosphatase 2, regulatory subunit A, alpha 5518 A8K7B7 AP-MS
Goudreault M , et al. 2008
PRDM14 PR domain zinc finger protein 14 63978 Q9GZV8 IP; LC-MS/MS
Huttlin EL , et al. 2015
RAD21 RAD21 homolog (S. pombe) 5885 O60216 IP; MS
Panigrahi AK , et al. 2011
STK24 serine/threonine kinase 24 8428 Q9Y6E0 AP-MS
Goudreault M , et al. 2008
STRN striatin, calmodulin binding protein 6801 O43815 AP-MS
Goudreault M , et al. 2008
STRN3 striatin, calmodulin binding protein 3 29966 Q13033 AP-MS
Goudreault M , et al. 2008
STRN4 striatin, calmodulin binding protein 4 29888 Q9NRL3 AP-MS
Goudreault M , et al. 2008
TCP1 t-complex 1 6950 P17987 AP-MS
Goudreault M , et al. 2008
ZRANB1 zinc finger, RAN-binding domain containing 1 54764 Q9UGI0 IP; MS; COMPASS
Sowa ME , et al. 2009
Cttn cortactin 60465 Q66HL2 GST; Blot overlay assay
Ohoka Y and Takai Y 1998

HELP
Copyright © 2017 MindSpec, Inc.